{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Suresh S"],"pubmed_abstract":["Phosphatidylinositol 4 kinase IIIα (PI4KIIIα/PI4KA) is an essential lipid kinase that plays a critical role in regulating plasma membrane identity. PI4KA is primarily recruited to the plasma membrane through the targeted recruitment by the proteins, EFR3A and EFR3B, which bind to the PI4KA accessory proteins TTC7 (TTC7A/B) and FAM126 (FAM126A/B). Here we characterised how both EFR3 isoforms interact with all possible TTC7-FAM126 combinations and developed a nanobody that specifically blocked EFR3-mediated PI4KA recruitment in TTC7B containing complexes. Most EFR3-TTC7-FAM126 combinations show similar binding affinities, with the exception of EFR3A-TTC7B-FAM126A, which binds with a ~10-fold higher affinity. Moreover, we showed that EFR3B phosphorylation markedly decreased binding to TTC7-FA"],"journal":["bioRxiv : the preprint server for biology"],"pagination":["2025.07.28.667261"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12747262"],"repository":["biostudies-literature"],"pubmed_title":["Development of an inhibitory TTC7B selective nanobody that blocks EFR3 recruitment of PI4KA."],"pmcid":["PMC12747262"],"pubmed_authors":["Yip CK","Balla T","Burke JE","Rohilla P","Suresh S","Cobb JA","Hansen SD","Akintola DK","Shaw AL","Doerr S","Lunke M"],"additional_accession":[]},"is_claimable":false,"name":"Development of an inhibitory TTC7B selective nanobody that blocks EFR3 recruitment of PI4KA.","description":"Phosphatidylinositol 4 kinase IIIα (PI4KIIIα/PI4KA) is an essential lipid kinase that plays a critical role in regulating plasma membrane identity. PI4KA is primarily recruited to the plasma membrane through the targeted recruitment by the proteins, EFR3A and EFR3B, which bind to the PI4KA accessory proteins TTC7 (TTC7A/B) and FAM126 (FAM126A/B). Here we characterised how both EFR3 isoforms interact with all possible TTC7-FAM126 combinations and developed a nanobody that specifically blocked EFR3-mediated PI4KA recruitment in TTC7B containing complexes. Most EFR3-TTC7-FAM126 combinations show similar binding affinities, with the exception of EFR3A-TTC7B-FAM126A, which binds with a ~10-fold higher affinity. Moreover, we showed that EFR3B phosphorylation markedly decreased binding to TTC7-FA","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-07-05T03:11:31.93Z","creation":"2026-07-05T03:08:26.234Z"},"accession":"S-EPMC12747262","cross_references":{"pubmed":["41473329"],"doi":["10.1101/2025.07.28.667261"]}}